Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spirecut’s patented ultrasound-guided, incision-free instruments—Sono-Instruments®—are CE-marked and FDA registered. Over 2,000 successful procedures have been performed in Switzerland and internationally. Clinical publications highlight rapid patient recovery, minimal discomfort, and the ability to treat multiple conditions concurrently[4][5].
The company has established a Center of Excellence in Geneva for training and research into further applications of its technology[5].
Distribution agreements are in place across Europe and North America as part of ongoing commercial expansion[4].
No pharmacological clinical trials are involved as this is a device-based intervention.
The company recently completed a Series A funding round to support growth into new markets including the US[4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spirecut.